<DOC>
	<DOCNO>NCT00756990</DOCNO>
	<brief_summary>This investigation involve use long-acting , injectable form ( depot ) naltrexone treatment person history opioid dependence , 40 parole/probation 20 non-parolees . The test pilot study 60 subject treat 6 month depot naltrexone plus Psychosocial Treatment .</brief_summary>
	<brief_title>Depot Naltrexone Treatment Opioid Dependent Parolees</brief_title>
	<detailed_description>This two phase study . Phase 1 complete phase 2 yet recruit .</detailed_description>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Inclusion/Exclusion Criteria . To eligible participate , participant must : sign informed consent form ; age 18 55 ; diagnosis opioid dependence accord DSM IVTR criterion ; good general health determine complete physical examination laboratory test ; assign probation/parole period least six month ; ( except participant parole/probation , see note ) ; negative result urinary opioids must self report least 3 day opioid free . Participants may diagnosis alcohol dependence long severe alcohol dependence require medical supervision alcohol withdrawal . Participants follow characteristic exclude study participation : current severe alcohol dependence require medical supervision alcohol withdrawal ; current psychosis , dementia , mental retardation , history schizophrenia ; significant clinical abnormality hematology , chemistry , urinalysis ; significant clinical cardiovascular , neurological , hepatic , renal , pulmonary , metabolic , endocrine , gastrointestinal disorder ; female subject pregnant lactating , female subject childbearing potential use birth control ( oral contraceptive , barrier ( diaphragm condom ) plus spermicide , levonorgestriel implant ) ; subject take opioid antagonist within prior 6 month ; current diagnosis chronic pain disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>